A comprehensive view of Prescription Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Vectura Fertin Pharma to sell Vectura Group to Molex for GBP 150M upfront; PMI subsidiary establishes master service agreements for inhaled therapeutics pipeline development
Published: September 17, 2024 by Philip Morris International Inc.
Orifarm Group acquires pharmaceutical portfolio from Takeda for up to €615 million; Carlyle Global Credit commits strategic capital to support Orifarm's growth, transaction expected to close Q4 2024
Published: September 14, 2024 by Contify Life Science News
CA AB3063: Requires pharmacies to obtain a sterile compounding license and adhere to U.S. Pharmacopeia-National Formulary standards for drug preparation.
Published: September 13, 2024 by California 2023-2024 Session
Survey: 63% of rheumatic condition patients substitute cannabis for prescription drugs; respondents cite better symptom management, fewer side effects as reasons
Published: September 12, 2024 by National Organization for the Reform of Marijuana Laws (NORML)
NJ A4682: Prohibits insurance carriers from denying nonopioid drug coverage in favor of opioids.
Published: September 12, 2024 by New Jersey 2024-2025 Regular Session

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count